Institutional Fund
Great Point Partners LLC
Greenwich, CTCIK 12814465 filings on record
Portfolio Value
$408.27M
Q1 2026
Holdings
39
Reported positions
New Buys
18
Opened this quarter
QoQ Change
+32.4%
from $308.41M
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Apogee Therapeutics Inc7.7%
- Vor Biopharma Inc7.6%
- Zura Bio Ltd6.1%
- Amylyx Pharmaceuticals Inc6.0%
- Nektar Therapeutics5.6%
- Sol Gel Technologies5.3%
- Other61.6%
Portfolio Holdings
39 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Apogee Therapeutics Inc | 374.0K | $31.48M | 7.7% | 0 | Held |
| 2 | Vor Biopharma Inc | 1.75M | $31.22M | 7.6% | +379.9K | Added |
| 3 | Zura Bio Ltd | 4.22M | $25.08M | 6.1% | +400.0K | Added |
| 4 | Amylyx Pharmaceuticals Inc | 1.75M | $24.32M | 6.0% | 0 | Held |
| 5 | Nektar Therapeutics | 316.5K | $22.77M | 5.6% | +105.7K | Added |
| 6 | Sol Gel Technologies | 274.4K | $21.74M | 5.3% | +274.4K | New |
| 7 | Alumis Inc | 856.1K | $18.86M | 4.6% | +856.1K | New |
| 8 | Bright Minds Biosciences Inc | 220.0K | $16.05M | 3.9% | +220.0K | New |
| 9 | Annexon Inc | 2.50M | $13.85M | 3.4% | +2.50M | New |
| 10 | Kalvista Pharmaceuticals Inc | 675.0K | $13.59M | 3.3% | −10.6K | Reduced |
29 more holdings on Premium
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio